• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Kids v Cancer

A PEDIATRIC CANCER THINK TANK

DONATE
  • GIVE KIDS A CHANCE act
  • RACE for Children Act
  • Creating Hope Act Pediatric Vouchers
  • CLIMB THE HILL
    • What is Climb the Hill Day?
    • Climb the Hill Youth Advocacy Day Sign Up
    • Video and photo gallery
    • (video) Climb the Hill Youth Advocacy Day — Why Do We Do It?
  • Compassionate Use Navigator
    • Information for Families
    • Information for Physicians
  • Who We Are
    • About Us
    • Mission and Impact
    • Contact
  • News & publications
    • Kids v Cancer in the News
    • Kids v Cancer Publications

(Guidance) FDA Updates Draft Guidance on Pediatric Priority Review Vouchers

July 30, 2019

July 2020: FDA expects to receive 51 rare pediatric disease designation requests and 20 priority review voucher requests annually. It also estimates that 3 vouchers will be redeemed and 2 will be sold per year. (See the Federal Register notice).

Since the passage of the Creating Hope Act in 2012, 19 new rare pediatric disease medicines were awarded priority review vouchers. See the full list.

The revised draft guidance incorporates public comments received on the initial draft and provides FDA’s thinking regarding the provisions of the Advancing Hope Act of 2016, which updated the definition of a rare pediatrics disease.

The full draft guidance text: Rare Pediatric Disease Priority Review Vouchers — Guidance for Industry.

  • We are in the news
  • Our Publications
  • Our Op-Eds & Speeches
  • Legislation / Proclamations
  • Videos / Photos
  • RELEVANT NEWS
    • RACE for Children Act
    • Creating Hope Act/ Pediatric vouchers
    • Compassionate Use
    • Kids’ Eligibility for Trials
  • Facebook
  • Twitter

DONATE SUBSCRIBE

Kids v Cancer · 3602 Newark Street NW · Washington D.C. 20016 · 646-361-3590 · contact

© 2023 Kids v Cancer · All Rights Reserved a 501(c)(3) nonprofit organization · EIN 27-1427784 · Privacy Policy · Terms of Use · Sitemap